DK3288578T5 - Sammensætninger til colonrensning og behandling af gastrointestinale lidelser - Google Patents

Sammensætninger til colonrensning og behandling af gastrointestinale lidelser Download PDF

Info

Publication number
DK3288578T5
DK3288578T5 DK16721609.2T DK16721609T DK3288578T5 DK 3288578 T5 DK3288578 T5 DK 3288578T5 DK 16721609 T DK16721609 T DK 16721609T DK 3288578 T5 DK3288578 T5 DK 3288578T5
Authority
DK
Denmark
Prior art keywords
compositions
treatment
gastrointestinal disorders
colon cleansing
cleansing
Prior art date
Application number
DK16721609.2T
Other languages
Danish (da)
English (en)
Other versions
DK3288578T3 (da
Inventor
Christopher Leitheiser
Mark G Currie
Robert Solinga
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Publication of DK3288578T3 publication Critical patent/DK3288578T3/da
Application granted granted Critical
Publication of DK3288578T5 publication Critical patent/DK3288578T5/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK16721609.2T 2015-05-01 2016-04-29 Sammensætninger til colonrensning og behandling af gastrointestinale lidelser DK3288578T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562156077P 2015-05-01 2015-05-01
PCT/US2016/030061 WO2016178979A1 (en) 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders

Publications (2)

Publication Number Publication Date
DK3288578T3 DK3288578T3 (da) 2023-05-01
DK3288578T5 true DK3288578T5 (da) 2024-10-07

Family

ID=55953439

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16721609.2T DK3288578T5 (da) 2015-05-01 2016-04-29 Sammensætninger til colonrensning og behandling af gastrointestinale lidelser

Country Status (23)

Country Link
US (2) US10618938B2 (enExample)
EP (2) EP3288578B8 (enExample)
JP (5) JP6930919B2 (enExample)
KR (2) KR102783759B1 (enExample)
CN (2) CN108040482B (enExample)
CA (2) CA3172777A1 (enExample)
CY (1) CY1126031T1 (enExample)
DK (1) DK3288578T5 (enExample)
EA (1) EA201792401A1 (enExample)
ES (1) ES2947591T3 (enExample)
FI (1) FI3288578T3 (enExample)
HR (1) HRP20230381T1 (enExample)
HU (1) HUE061954T2 (enExample)
LT (1) LT3288578T (enExample)
MA (1) MA41985B1 (enExample)
MD (1) MD3288578T2 (enExample)
MX (2) MX2017013928A (enExample)
PL (1) PL3288578T3 (enExample)
PT (1) PT3288578T (enExample)
RS (1) RS64160B1 (enExample)
SI (1) SI3288578T1 (enExample)
SM (1) SMT202300114T1 (enExample)
WO (1) WO2016178979A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6930919B2 (ja) * 2015-05-01 2021-09-01 アイアンウッド ファーマシューティカルズ インコーポレイテッド 結腸洗浄及び胃腸障害の治療のための組成物
PL3464336T3 (pl) 2016-06-01 2022-05-16 Athira Pharma, Inc. Związki
JP2024541769A (ja) * 2021-11-24 2024-11-12 アイアンウッド ファーマシューティカルズ， インコーポレイテッド 修飾ｇｃｃ受容体アゴニストの産生のための合成プロセス
AU2022397387A1 (en) * 2021-11-24 2024-05-30 Ironwood Pharmaceuticals, Inc. Synthetic process for production of modified gcc receptor agonists
JP2024541570A (ja) 2021-11-29 2024-11-08 アイアンウッド ファーマシューティカルズ， インコーポレイテッド 内臓痛の処置のための医薬組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
DE602004007105T2 (de) * 2003-01-28 2008-02-28 Microbia Inc., Cambridge Zusammensetzung zur behandlung von gastrointestinalen störungen
US7494979B2 (en) * 2003-06-13 2009-02-24 Ironwood Pharmaceuticals, Inc. Method for treating congestive heart failure and other disorders
EP1940441A4 (en) * 2005-08-19 2010-01-27 Ironwood Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL DISORDERS
WO2010025510A1 (en) * 2008-09-03 2010-03-11 Xenome Ltd Libraries of peptide conjugates and methods for making them
EA201290799A1 (ru) * 2010-02-17 2013-03-29 Айронвуд Фармасьютикалз, Инк. Лечение желудочно-кишечных расстройств
EP3366698A1 (en) * 2011-03-01 2018-08-29 Synergy Pharmaceuticals Inc. Guanylate cyclase c agonists
AU2014218599C1 (en) * 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2016015055A1 (en) 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Colon cleansing compositions
JP6930919B2 (ja) * 2015-05-01 2021-09-01 アイアンウッド ファーマシューティカルズ インコーポレイテッド 結腸洗浄及び胃腸障害の治療のための組成物

Also Published As

Publication number Publication date
JP6930919B2 (ja) 2021-09-01
PT3288578T (pt) 2023-03-28
KR102783759B1 (ko) 2025-03-21
JP2025169325A (ja) 2025-11-12
EP4218789A3 (en) 2023-09-27
CY1126031T1 (el) 2023-11-15
EP3288578B1 (en) 2023-03-15
KR20250042844A (ko) 2025-03-27
EP3288578A1 (en) 2018-03-07
SI3288578T1 (sl) 2023-07-31
US10618938B2 (en) 2020-04-14
DK3288578T3 (da) 2023-05-01
JP2024015335A (ja) 2024-02-01
CN114716514A (zh) 2022-07-08
KR20180005675A (ko) 2018-01-16
JP2022121734A (ja) 2022-08-19
JP2020203954A (ja) 2020-12-24
HUE061954T2 (hu) 2023-09-28
US20180148476A1 (en) 2018-05-31
CN108040482A (zh) 2018-05-15
EP3288578B8 (en) 2023-03-29
CA2984437C (en) 2025-11-18
SMT202300114T1 (it) 2023-05-12
MX2022013283A (es) 2022-12-13
CN108040482B (zh) 2022-03-29
FI3288578T3 (fi) 2023-05-03
MA41985B1 (fr) 2023-04-28
RS64160B1 (sr) 2023-05-31
CA2984437A1 (en) 2016-11-10
BR112017023539A2 (pt) 2018-08-14
HRP20230381T1 (hr) 2023-07-07
PL3288578T3 (pl) 2023-08-14
LT3288578T (lt) 2023-04-25
MD3288578T2 (ro) 2023-08-31
US20240199697A1 (en) 2024-06-20
EA201792401A1 (ru) 2018-05-31
ES2947591T3 (es) 2023-08-11
MA41985A (fr) 2018-03-07
MX2017013928A (es) 2018-01-15
JP2018519254A (ja) 2018-07-19
WO2016178979A1 (en) 2016-11-10
CA3172777A1 (en) 2016-11-10
EP4218789A2 (en) 2023-08-02

Similar Documents

Publication Publication Date Title
DK3224269T3 (da) Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
DK3185876T3 (da) Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser
DK3570844T3 (da) Azolopyrimidin til behandlingen af kræftrelaterede lidelser
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3277815T3 (da) Oligonukleotidforbindelser til behandling af præeklampsi og andre angiogene lidelser
DK3119797T3 (da) Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose
DK3212226T3 (da) Sammensætninger og anvendelsesfremgangsmåder til behandling af metaboliske lidelser
DK3402499T3 (da) Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes
DK3206493T3 (da) Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
DK3600270T3 (da) Forbindelser og sammensætninger til behandling af hæmatologiske lidelser
DK3102213T3 (da) Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser
DK3269716T3 (da) Hidtil ukendte forbindelser og farmaceutiske sammensætninger deraf til behandling af inflammatoriske lidelser
DK3277270T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK3250210T3 (da) Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
DK3685848T3 (da) Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension
DK3209696T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom
DK3238707T3 (da) Sammensætninger og fremgangsmåder til behandling af intestinal hyperpermeabilitet
DK3189074T3 (da) Sammensætninger og metoder til behandling og forebyggelse af inflammation
DK3142664T3 (da) Sammensætninger og fremgangsmåder til behandling og diagnosticering af øjensygdomme
DK3261644T3 (da) Sammensætninger og fremgangsmåder til behandling af nethindenedbrydning
DK3723768T3 (da) Forbindelser til behandling og forebyggelse af patologier medieret af ekstracellulære histoner
DK3522873T3 (da) Sammensætninger og fremgangsmåder til behandlingen af xerostomi
DK3256466T3 (da) 1-heterocyclyl-isochromanylforbindelser og analoger til behandling af cns-forstyrrelser
DK3386507T3 (da) Metoder og sammensætninger til behandling af mavesår